Related references
Note: Only part of the references are listed.The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo
Andrea P. Martin et al.
JOURNAL OF IMMUNOLOGY (2006)
Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity
Gabriele S. V. Campanella et al.
JOURNAL OF IMMUNOLOGY (2006)
Membrane-bound CC chemokine inhibitor 35K provides localized inhibition of CC chemokine activity in vitro and in vivo
Christina A. Bursill et al.
JOURNAL OF IMMUNOLOGY (2006)
Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system
Z Johnson et al.
JOURNAL OF IMMUNOLOGY (2004)
Cutting edge: IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation
A Krug et al.
JOURNAL OF IMMUNOLOGY (2002)
The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium
YQ Huo et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium
P von Hundelshausen et al.
CIRCULATION (2001)
Share Paper
